Perbedaan BFI Finance Indonesia Tbk dan UBC Medical Indonesia Tbk.: BFI Finance Indonesia Tbk diperdagangkan di Rp900 (kapitalisasi pasar 13,76 T, volume 24 jam 12,86 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp164 (kapitalisasi pasar 635,95 M, volume 24 jam 205,8 rb). Perbedaan utamanya: BFI Finance Indonesia Tbk jauh lebih besar — sekitar 21,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan BFI Finance Indonesia Tbk lebih aktif diperdagangkan (12,86 jt vs 205,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BFIN | LABS | |
|---|---|---|
Kapitalisasi Pasar | 13,76 T | 635,95 M |
Volume | 12,86 jt | 205,8 rb |
Lot | 128,58 rb | 2,06 rb |
Perputaran | 11,61 M | 33,49 jt |
Harga Rata-rata | 902,86 | 162,73 |
Nilai Transaksi | 11,61 M | 33,49 jt |
Harga Ekuilibrium Indikatif | 910 | 163 |
Volume Ekuilibrium Indikatif | 194 | 16 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Selengkapnya di halaman BFIN →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →